Keywords: celgene, 1st-qtr, net, income, soars, drugmaker, says
Celgene's 1st-qtr 2007 net income soars 61.4%
Article | 28 May 2007
US drugmaker Celgene says that its first-quarter 2007 net income totaled $57.4 million, $0.14 per diluted share, versus $16.0 million, or $0.04 per share, in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
